¿Podría una píldora vibradora aliviar el estreñimiento crónico?
JUEVES, 9 de febrero de 2023 (HealthDay News) — Un nuevo tratamiento para el estreñimiento crónico podría ofrecer alivio, sin tener que usar ningún medicamento.Se trata de una píldora llamada Vibrant, que estimula al colon a medida que se desplaza po…
Learn MoreCould a Vibrating Pill Ease Chronic Constipation?
THURSDAY, Feb. 9, 2023 (HealthDay News) — A new treatment for chronic constipation may bring relief without having to use drugs. It’s a vibrating pill called Vibrant that stimulates the colon as it passes through the body.Although the pill was approv…
Learn MoreFDA Approves New Drug for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
MONDAY, Jan. 23, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved zanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.The ap…
Learn MoreFDA Approves New Two-Drug Combo Medicine for Asthma
THURSDAY, Jan. 12, 2023 (HealthDay News) — Adults with asthma now have a new rescue medication to turn to after the U.S. Food and Drug Administration approved Airsupra on Wednesday. The drug is the first approved to combine albuterol and budesonide.A…
Learn MoreFDA Approves New 2-Drug Combo Medicine for Asthma
THURSDAY, Jan. 12, 2023 (HealthDay News) — Adults with asthma now have a new rescue medication to turn to after the U.S. Food and Drug Administration approved Airsupra on Wednesday.The drug is the first approved to combine albuterol (a beta-2 adrener…
Learn MoreFDA Approves Second Drug for Alzheimer Disease, Despite Safety Concerns
FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second drug for Alzheimer disease, Leqembi (lecanemab-irmb), despite reports of rare brain bleeds linked to use of the drug in some patients.Leqembi, m…
Learn MoreFDA Approves Sunlenca for Treatment-Resistant HIV
THURSDAY, Dec. 29, 2022 (HealthDay News) — The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with…
Learn MoreFDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer
MONDAY, Dec. 19, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin (nadofaragene firadenovec-vncg), which is designed to work for patients with high-risk non-muscle-invasive bladder can…
Learn MoreFirst FDA-Approved Fecal-Based Treatment Helps Fight a Tough Superbug
THURSDAY, Dec. 1, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections.”Today’s approval o…
Learn MoreLa FDA aprueba una terapia genética para la hemofilia que cuesta 3.5 millones de dólares
MIÉRCOLES, 23 de noviembre de 2022 (HealthDay News) — Las personas con una forma de hemofilia, un trastorno genético de la sangre, tienen ahora un tratamiento, que se administra una sola vez, que cuesta 3.5 millones de dólares.La Administración de Al…
Learn More